Objective: To study the demographic and clinical features of patients diagnosed with lung cancer at our hospital and the stage of disease at presentation in various histopathology subtypes.
Introduction
Lung cancer is the second most common malignancy in Jordan and worldwide.
(1,2) It is the cause of cancer-related death.
(3) It is estimated that 1.8 million patients diagnosed with lung cancer in 2012 and that resulted in 1.6 million deaths.
(4)
Smoking is the most causative and preventable cause of lung cancer.
(5) In an only minority of patients, the disease diagnosed at early stage, and most patients presented with advanced stages.
(6) The prognosis and overall survival of patients with lung cancer didn't change in the past decades. Lung cancer is divided into small cell lung cancer (SCLC) in 15 % of patients and non-small cell lung cancer (NSCLC) in 85 % of patients.
(8) NSCLC further divided into squamous cell and non-squamous cell.
A recent classification was adopted because new molecular targeted drugs tend to be preferentially associated with adenocarcinoma rather than squamous cell carcinoma, and certain chemotherapeutic agents show favorable outcomes in each histological type.
(9, 10) New studies showed a benefit of low dose chest CT for screening of lung cancer . (11) The most common diagnostic modality of lung cancer is Bronchoscopy with bronchial biopsy, it is the most accurate and safe modality of diagnoses and it carries low morbidity.
(12) Pathological assessment of bronchial biopsy needs multistep process, starting from morphology assessment to immunohistochemistry (IHC) when required followed by appropriate molecular characterization of the tumor. (13) After diagnosis, staging with CT scan, Brain MRI, Positron emission tomography-computed tomography (PET-CT), and Bone scan are a must. PET-CT scan used for proper staging of disease particularly to assess mediastinal lymph nodes, liver, bone, lung and adrenal metastasis.
(14)
Lobectomy and pneumonectomy are the curative procedures in early stages of the disease.
(15) The aim of our study is to identify the demographic and clinical features of patients diagnosed with lung cancer at our hospital and the stage of disease at presentation in various histopathology subtypes. 
Methods

Results
A total 112 patients diagnosed with lung cancer between January 2014 and August 2015 were included in our study;96 patients were males (85.7%) and 16 patients were females (14.3%), whom age range from 22 years to 85 years with mean age of 62.2 years. Mean age in males was 63 years and females 56 years, p-value 0.03. Distribution of all patients according to age was described in (Table I) . Most of our cohort 56 patients (50%) were symptomatic at presentation. Cough, dyspnea were reported in 40 (35%) patients , hemoptysis in 25(22%) patients, weight loss in 10 (9%) patients and bone pain in 7 (6%) patients. Regarding the major histological types, it was found that SCLC accounted for 23.2% (26 patients), NSCLC accounted for 76.8% (86 patients); (squamous cell carcinomas 59.3%, adenocarcinoma 25.5 %, Non-small cell carcinoma NOS 11.6 %, others 3.4%). Histopathology subtypes illustrated in (Table II) .The mean age at diagnosis of NSCLC was 62.2 years while in SCLC was 60. 76 patients (79%) were males diagnosed with NSCLC while (20patients) (21%) were diagnosed with SCLC. 10 patients (62%) were females with NSCLC and 6 patients (38%) had SCLC. Of our patients 88% (99 patients) diagnosed with lung cancer are smokers, most were males (93%) while 56 % of females with lung cancer are smokers. 92 %, 87% of patients are smokers among subjects with SCLC, NSCLC, respectively. Stage of disease to all patients at presentation is in (Table III) and sites of metastasis at the presentation in (Table IV) . Nowadays it is leading cause of cancerrelated deaths in both males and females in the United States.
(18) Lung cancer is the disease of advanced age; it is strongly related to age. The majority of patients with lung cancer were 70 years or older. (19) The median age at diagnosis in our study was 62.2 years, with a minimum of 22 years and a maximum of 85 years. The median age at diagnosis was 63 years for males and 56 years for females. It seems that our patients with lung cancer are younger than those patients in the UK, where almost nine in ten cases were diagnosed in those aged 60 and over. While in our study 40% of patients were less than 60 years, that suggests lung cancer affects younger ages in Jordan, and some patients diagnosed at young age of 20s and 30s, females were relatively younger in our cohort than males 56 vs 63 years. The lung cancer incidence continues to be higher in men than women.
(21) Most patients in our cohort were males 85% vs 15% females. However, the magnitude of this difference may decrease in the next years as the result of increased use of tobacco among females. Lung cancer in females has been increasing in the past few years while it has been decreasing in men. (22) Nearly all patients in our study were symptomatic at the time of diagnosis; half of patients complained of cough and third complained of dyspnea. Because there is no surveillance program for lung cancer in Jordan, this lead to patients presenting with lung cancer at an advanced stage. Approximately 77% of our patients had NSCLC, and only 23% had SCLC histology. Worldwide SCLC accounts for approximately 15% of all lung cancer cases, and it is strongly associated with smoking.
(23) SCLC rarely seen in the never smoker and virtually all of the never-smokers had NSCLC, the higher percentage of SCLC among our patients in relative to other countries may be related to the higher percentage of smokers in our community. Although SCLC is initially more responsive to chemotherapy and radiation therapy than all other lung cancer types, it is very difficult to cure, due to its aggressive growth and its wide dissemination at the time of diagnosis.
(24)
Most of NSCLC histology in our patients was squamous cell carcinoma which was documented in 59% of patients and 25% had adenocarcinoma, NSCLC NOS in 11%, large cell in two patients and sarcomatoid carcinoma in one patient. In comparison with cohorts in western countries and USA which suggest that adenocarcinoma is becoming the most common histological type. In the late 1950s,squamous cell histology was the commonest histopathology worldwide and few patients were adenocarcinoma, but in the following years according to data in the US National Surveillance Epidemiology and End Results SEER tumor registries the prevalence of adenocarcinoma rose sharply so that by 1980s , the prevalence of adenocarcinoma exceeded that of squamous cell histology.
(26) Smoking associated with all histology of lung cancer but it is linked stronger with squamous and small cell histology.
(29) It is also noticed that our female patients had more adenocarcinoma than squamous cancer. It is estimated that 90% of all cases of lung cancer related to cigarette smoking according to IARC (International Agency for Research on Cancer), there is a wide variation in lung cancer incidence among smokers.
(30) In our study there is clear difference in the distribution of histology subtypes of lung cancer, half of female patients were adenocarcinoma and this finding is similar to many studies were done outside; in population-based case-control study of 4220 people in Italy demonstrated that 54 percent of females had adenocarcinoma. (36) In the present study, the incidence of distant metastasis at the time of initial diagnosis of lung cancer was 68% in 76 patients, 73 % of patients with NSCLC presented with metastatic stage and 50% of SCLC presented with extensive stage. This percentage is higher than many studies which determined that 40-60% of patients present with metastatic disease.
(37)
Most common sites of metastasis were lung followed by the liver, bone, brain and adrenal glands. Most patients in metastatic stage presented with more than one site of metastasis, probably related to the delay in presentation and diagnosis. Many studies emphasize that the prognosis of metastatic lung cancer is related to the bulk and number of metastatic sites. Oh et al reported that an increasing number of metastatic organ sites correlated with decreased survival.
(30)
Similarly, patients with oligometastatic NSCLC had better prognosis than did those with multiple metastasis. Limitations of the study: Our study is limited by its small size (N = 112), by the fact that it is a retrospective analysis and, therefore, subject to bias from incomplete data availability, and by the biases inherent in it being a singlecenter study at a tertiary referral institution.
Conclusions
Accepting the aforementioned limitations inherent to our study methodology, we observed that squamous cell carcinoma was still the predominant histopathology in our patients which is strongly associated with smoking. Most our patients were symptomatic at the time of diagnosis, and significant number of those were diagnosed in metastatic stage. These findings emphasize that early diagnosis is important; this could be done with screening programs for lung cancer. Newer modalities such as Low-Dose Computed Tomography (LDCT) may prove to be clinically effective for screening at-risk populations and result in more patients being diagnosed with early stage disease. Further strengthening current tobacco control measures is critical in reducing the prevalence of lung cancer particularly in women. 
